{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:08:03Z","timestamp":1770883683242,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11845-023-03280-2","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T13:02:42Z","timestamp":1674478962000},"page":"2541-2547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum paraoxonase activities, nitric oxide, and malondialdehyde levels are altered in patients with primary fibromyalgia syndrome"],"prefix":"10.1007","volume":"192","author":[{"given":"Yildiz","family":"Atamer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Sarac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice Kubra","family":"As\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-8991","authenticated-orcid":false,"given":"Tugba","family":"Sahbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"issue":"8","key":"3280_CR1","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/ijms22083891","volume":"22","author":"R Siracusa","year":"2021","unstructured":"Siracusa R, Paola RD, Cuzzocrea S et al (2021) Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci 22(8):3891. https:\/\/doi.org\/10.3390\/ijms22083891","journal-title":"Int J Mol Sci"},{"issue":"21","key":"3280_CR2","doi-asserted-by":"publisher","first-page":"7877","DOI":"10.3390\/ijms21217877","volume":"21","author":"ME Maffei","year":"2020","unstructured":"Maffei ME (2020) Fibromyalgia: recent advances in diagnosis, classification, pharmacotherapy and alternative remedies. Int J Mol Sci 21(21):7877. https:\/\/doi.org\/10.3390\/ijms21217877","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3280_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/art.21533","volume":"54","author":"RS Katz","year":"2006","unstructured":"Katz RS, Wolfe F, Michaud K (2006) Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 54(1):169\u2013176","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3280_CR4","first-page":"140","volume":"34","author":"M Topbas","year":"2005","unstructured":"Topbas M, Cakirbay H, Gulec H et al (2005) The prevalence of fibromyalgia in women aged 20\u201364 in Turkey. Scand J Rheumatol 34(2):140\u2013144","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"3280_CR5","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.2174\/1386207323999201103203153","volume":"24","author":"M Ahmadnezhad","year":"2021","unstructured":"Ahmadnezhad M, Ghazizadeh H, Bijari M et al (2021) Serum pro-oxidant-antioxidant balance in subjects with type 2 diabetes mellitus. Comb Chem High Throughput Screen 24(9):1476\u20131481. https:\/\/doi.org\/10.2174\/1386207323999201103203153","journal-title":"Comb Chem High Throughput Screen"},{"key":"3280_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.clnesp.2020.05.019","volume":"38","author":"A Bagherifard","year":"2020","unstructured":"Bagherifard A, AminiKadijani A, Yahyazadeh H et al (2020) The value of serum total oxidant to the antioxidant ratio as a biomarker of knee osteoarthritis. Clin Nutr ESPEN 38:118\u2013123. https:\/\/doi.org\/10.1016\/j.clnesp.2020.05.019","journal-title":"Clin Nutr ESPEN"},{"key":"3280_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cbf.1224","volume":"24","author":"G Baskol","year":"2006","unstructured":"Baskol G, Baskol M, Yurci A et al (2006) Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis. Cell Biochem Func 24:283\u2013286","journal-title":"Cell Biochem Func"},{"issue":"4","key":"3280_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/cbf.15487","volume":"27","author":"S Akku\u015f","year":"2009","unstructured":"Akku\u015f S, Naziro\u011flu M, Eri\u015f S et al (2009) Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia. Cell Biochem Funct 27(4):181\u2013185. https:\/\/doi.org\/10.1002\/cbf.15487","journal-title":"Cell Biochem Funct"},{"key":"3280_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.pain.2005.10.032","volume":"120","author":"KL McIver","year":"2006","unstructured":"McIver KL, Evans C, Kraus RM et al (2006) NO-mediated alterations in skeletal muscle nutritive blood flow and lactate metabolism in fibromyalgia. Pain 120:161\u2013169","journal-title":"Pain"},{"issue":"2","key":"3280_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1054\/mehy.2001.1325","volume":"57","author":"ML Pall","year":"2001","unstructured":"Pall ML (2001) Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide\/peroxynitrite. Med Hypotheses 57(2):139\u2013145","journal-title":"Med Hypotheses"},{"key":"3280_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00296-005-0079-y","volume":"26","author":"S Ozgocmen","year":"2006","unstructured":"Ozgocmen S, Ozyurt H, Sogut S et al (2006) Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 26:598\u2013603","journal-title":"Rheumatol Int"},{"issue":"6 Suppl 79","key":"3280_CR12","first-page":"S128","volume":"31","author":"G Fatima","year":"2013","unstructured":"Fatima G, Das SK, Mahdi AA (2013) Oxidative stress and antioxidative parameters and metal ion content in patients with fibromyalgia syndrome: implications in the pathogenesis of the disease. Clin Exp Rheumatol 31(6 Suppl 79):S128\u2013S133","journal-title":"Clin Exp Rheumatol"},{"key":"3280_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1179\/135100006X116628","volume":"11","author":"O Altindag","year":"2006","unstructured":"Altindag O, Celik H (2006) Total antioxidant capacity and the severity of the pain in patients with fibromyalgia. Redox Rep 11:131\u2013135. https:\/\/doi.org\/10.1179\/135100006X116628","journal-title":"Redox Rep"},{"issue":"2","key":"3280_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1570161115666171129212359","volume":"17","author":"S Lioudaki","year":"2019","unstructured":"Lioudaki S, Verikokos C, Kouraklis G et al (2019) Paraoxonase-1: characteristics and role in atherosclerosis and carotid artery disease. Curr Vasc Pharmacol 17(2):141\u2013146. https:\/\/doi.org\/10.2174\/1570161115666171129212359","journal-title":"Curr Vasc Pharmacol"},{"issue":"24","key":"3280_CR15","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.3390\/molecules25245980","volume":"25","author":"A Taler-Ver\u010di\u010d","year":"2020","unstructured":"Taler-Ver\u010di\u010d A, Goli\u010dnik M, Bavec A (2020) The structure and function of paraoxonase-1 and its comparison to paraoxonase-2 and -3. Molecules 25(24):5980. https:\/\/doi.org\/10.3390\/molecules25245980","journal-title":"Molecules"},{"key":"3280_CR16","doi-asserted-by":"publisher","first-page":"4264314","DOI":"10.1155\/2022\/4264314","volume":"2022","author":"M Zuin","year":"2022","unstructured":"Zuin M, Trentini A, Marsillach J et al (2022) Paraoxonase-1 (PON-1) arylesterase activity levels in patients with coronary artery disease: a meta-analysis. Dis Markers 2022:4264314. https:\/\/doi.org\/10.1155\/2022\/4264314","journal-title":"Dis Markers"},{"issue":"3","key":"3280_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1179\/rer.2007.12.3.134","volume":"12","author":"O Altindag","year":"2007","unstructured":"Altindag O, Gur A, Calgan N et al (2007) Paraoxonase and arylesterase activities in fibromyalgia. Redox Rep 12(3):134\u2013138. https:\/\/doi.org\/10.1179\/rer.2007.12.3.134","journal-title":"Redox Rep"},{"issue":"6","key":"3280_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00296-008-0738-x","volume":"29","author":"OF Sendur","year":"2008","unstructured":"Sendur OF, Turan Y, Tastaban E et al (2008) Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int 29(6):629\u2013633. https:\/\/doi.org\/10.1007\/s00296-008-0738-x","journal-title":"Rheumatol Int"},{"issue":"8","key":"3280_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/antiox7080102","volume":"7","author":"G Barrera","year":"2018","unstructured":"Barrera G, Pizzimenti S, Daga M et al (2018) Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders. Antioxidants 7(8):102","journal-title":"Antioxidants"},{"issue":"10","key":"3280_CR20","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.7754\/clin.lab.2014.131017","volume":"60","author":"A Toker","year":"2014","unstructured":"Toker A, Kucuksen S, Kucuk A et al (2014) Serum ischemia-modified albumin and malondialdehyde levels and superoxide dismutase activity in patients with fibromyalgia. Clin Lab 60(10):1609\u20131615. https:\/\/doi.org\/10.7754\/clin.lab.2014.131017","journal-title":"Clin Lab"},{"issue":"1","key":"3280_CR21","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1080\/07853890.2021.1916069","volume":"53","author":"FE Hassan","year":"2021","unstructured":"Hassan FE, Sakr HI, Mohie PM et al (2021) Pioglitazone improves skeletal muscle functions in reserpine-induced fibromyalgia rat model. Ann Med 53(1):1032\u20131040. https:\/\/doi.org\/10.1080\/07853890.2021.1916069","journal-title":"Ann Med"},{"issue":"10","key":"3280_CR22","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.4103\/njcp.njcp_95_18","volume":"21","author":"TT Koca","year":"2018","unstructured":"Koca TT, Seyithanoglu M, Sagiroglu S et al (2018) Frequency of audiological complaints in patients with fibromyalgia syndrome and its relationship with oxidative stress. Niger J Clin Pract 21(10):1271\u20131277. https:\/\/doi.org\/10.4103\/njcp.njcp_95_18","journal-title":"Niger J Clin Pract"},{"key":"3280_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160\u2013172","journal-title":"Arthritis Rheum"},{"key":"3280_CR24","first-page":"3","volume":"7","author":"N Hisli","year":"1989","unstructured":"Hisli N (1989) Reliability and validity of Beck Depression Inventory among university students. J Turk Psychol 7:3\u201313","journal-title":"Journal of Turkish Psychology"},{"issue":"1","key":"3280_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s002960000077","volume":"20","author":"S Sarmer","year":"2000","unstructured":"Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 20(1):9\u201312. https:\/\/doi.org\/10.1007\/s002960000077","journal-title":"Rheumatol Int"},{"key":"3280_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02540959","volume":"15","author":"T Asakawa","year":"1980","unstructured":"Asakawa T, Matsushita S (1980) Coloring conditions of thiabarbituric acid test for detectinf lipid hydroperoxides. Lipids 15:137\u2013140","journal-title":"Lipids"},{"issue":"2","key":"3280_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0003-2697(89)90424-7","volume":"180","author":"CE Furlong","year":"1989","unstructured":"Furlong CE, Richter RJ, Seidel SL et al (1989) Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase\/arylesterase. Anal Biochem 180(2):242\u2013247. https:\/\/doi.org\/10.1016\/0003-2697(89)90424-7","journal-title":"Anal Biochem"},{"issue":"6 Pt 1","key":"3280_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/clinchem\/41.6.904","volume":"41","author":"PN Bories","year":"1995","unstructured":"Bories PN, Bories C (1995) Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 41(6 Pt 1):904\u2013907","journal-title":"Clin Chem"},{"key":"3280_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00296-003-0427-8","volume":"25","author":"S Bagis","year":"2005","unstructured":"Bagis S, Tamer L, Sahin G et al (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25:188\u2013190","journal-title":"Rheumatol Int"},{"key":"3280_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1365-2362.2006.01727.x","volume":"36","author":"M Gur","year":"2006","unstructured":"Gur M, Aslan M, Yildiz A et al (2006) Paraoxonase and arylesterase activities in coronary artery disease. Eur J of Clin Invest 36:779\u2013787","journal-title":"Eur J of Clin Invest"},{"key":"3280_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3959(00)00284-0","volume":"87","author":"AA Larson","year":"2000","unstructured":"Larson AA, Giovengo SL, Russel IJ et al (2000) Changes in the concentrations of aminoacids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia\u202f: implications for nitric oxide pathways. Pain 87:201\u2013211","journal-title":"Pain"},{"issue":"5","key":"3280_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.reuma.2010.12.007","volume":"7","author":"MD Cordero","year":"2011","unstructured":"Cordero MD (2011) Oxidative stress in fibromyalgia: pathophysiology and clinical implications. Reumatol Clin 7(5):281\u2013283","journal-title":"Reumatol Clin"},{"issue":"6","key":"3280_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.medcli.2010.01.030","volume":"136","author":"MD Cordero","year":"2011","unstructured":"Cordero MD, de Miguel M, Moreno-Fernandez AM (2011) Mitochondrial dysfunction in fibromyalgia and its implication in the pathogenesis of disease. Med Clin (Barc) 136(6):252\u2013256","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"3280_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11916-996-0010-6","volume":"8","author":"F Inanici","year":"2004","unstructured":"Inanici F, Yunus MB (2004) History of fibromyalgia: past to present. Curr Pain Headache Rep 8(5):369\u2013378","journal-title":"Curr Pain Headache Rep"},{"key":"3280_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1172\/JCI118074","volume":"96","author":"R De Caterina","year":"1995","unstructured":"De Caterina R, Libby P, Peng HB et al (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60\u201368","journal-title":"J Clin Invest"},{"key":"3280_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1590\/S0100-879X2005000700003","volume":"38","author":"JG Scandalios","year":"2005","unstructured":"Scandalios JG (2005) Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 38:995\u20131014","journal-title":"Braz J Med Biol Res"},{"key":"3280_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00296-006-0199-z","volume":"27","author":"B Alasehirli","year":"2007","unstructured":"Alasehirli B, Demiryurek S, Arica E et al (2007) No evidence for an association between the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and fibromyalgia syndrome. Rheumatol Int 27:275\u2013280","journal-title":"Rheumatol Int"},{"issue":"2","key":"3280_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2478\/jomb-2019-0033","volume":"39","author":"V Shukla","year":"2020","unstructured":"Shukla V, Kumar DS, Ali MA et al (2020) Nitric oxide, lipid peroxidation products, and antioxidants in primary fibromyalgia and correlation with disease severity. J Med Biochem 39(2):165\u2013170. https:\/\/doi.org\/10.2478\/jomb-2019-0033","journal-title":"J Med Biochem"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03280-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T01:11:19Z","timestamp":1695777079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03280-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3280"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03280-2","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}